Compounds > rosiglitazone
Page last updated: 2024-08-25

rosiglitazone and Nelson Syndrome

rosiglitazone has been researched along with Nelson Syndrome in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andreassen, M; Kristensen, LØ1
Atkinson, AB; Leslie, H; McCance, DR; Mullan, KR; Sheridan, B1
Ince, P; Munir, A; Newell-Price, J; Ross, R; Song, F; Walters, SJ1

Other Studies

3 other study(ies) available for rosiglitazone and Nelson Syndrome

ArticleYear
Rosiglitazone for prevention or adjuvant treatment of Nelson's syndrome after bilateral adrenalectomy.
    European journal of endocrinology, 2005, Volume: 153, Issue:4

    Topics: Adrenalectomy; Adrenocorticotropic Hormone; Adult; Aged; Female; Humans; Male; Nelson Syndrome; Rosiglitazone; Thiazolidinediones; Time Factors; Treatment Outcome

2005
The PPAR-gamma activator rosiglitazone fails to lower plasma ACTH levels in patients with Nelson's syndrome.
    Clinical endocrinology, 2006, Volume: 64, Issue:5

    Topics: Adrenalectomy; Adrenocorticotropic Hormone; Adult; Drug Administration Schedule; Humans; Middle Aged; Nelson Syndrome; Pituitary ACTH Hypersecretion; PPAR gamma; Rosiglitazone; Statistics, Nonparametric; Thiazolidinediones; Time Factors; Treatment Failure

2006
Ineffectiveness of rosiglitazone therapy in Nelson's syndrome.
    The Journal of clinical endocrinology and metabolism, 2007, Volume: 92, Issue:5

    Topics: ACTH-Secreting Pituitary Adenoma; Adrenocorticotropic Hormone; Adult; Aged; Anti-Inflammatory Agents; Female; Fludrocortisone; Humans; Hydrocortisone; Hypoglycemic Agents; Magnetic Resonance Imaging; Male; Nelson Syndrome; Pancreatitis; Pituitary ACTH Hypersecretion; Pituitary Gland; Pituitary Neoplasms; PPAR gamma; Rosiglitazone; Thiazolidinediones; Tomography, X-Ray Computed

2007